|
1
|
Siogkas PK, Papafaklis MI, Sakellarios AI,
Stefanou KA, Bourantas CV, Athanasiou LM, Bellos CV, Exarchos TP,
Naka KK, Michalis LK, et al: Computational assessment of the
fractional flow reserve from intravascular ultrasound and coronary
angiography data: A pilot study. Conf Proc IEEE Eng Med Biol Soc.
2013:3885–3888. 2013.PubMed/NCBI
|
|
2
|
Thygesen K, Alpert JS, Jaffe AS, Simoons
ML, Chaitman BR and White HD: Joint ESC/ACCF/AHA/WHF Task Force for
the Universal Definition of Myocardial Infarction. Katus HA,
Lindahl B, Morrow DA, et al: Third universal definition of
myocardial infarction. Circulation. 126:2020–2035. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Palmerini T, Benedetto U, Bacchi-Reggiani
L, Della Riva D, Biondi-Zoccai G, Feres F, Abizaid A, Hong MK, Kim
BK, Jang Y, et al: Mortality in patients treated with extended
duration dual antiplatelet therapy after drug-eluting stent
implantation: A pairwise and Bayesian network meta-analysis of
randomised trials. Lancet. 385:2371–2382. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hallas J, Dall M, Andries A, Andersen BS,
Aalykke C, Hansen JM, Andersen M and Lassen AT: Use of single and
combined antithrombotic therapy and risk of serious upper
gastrointestinal bleeding: Population based case-control study.
BMJ. 333:7262006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lippi G, Franchini M and Cervellin G:
Diagnosis and management of ischemic heart disease. Semin Thromb
Hemost. 39:202–213. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Flandre P, Boufassa F, Gerard L, Carre N,
Persoz A and Meyer L: The use of auxiliary events to improve the
analysis of survival for HIV-infected patients: application to the
French Prospective Multicenter Cohort (SEROCO). J Acquir Immune
Defic Syndr Hum Retrovirol. 12:174–181. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sperry SM, Charlton ME and Pagedar NA:
Association of sentinel lymph node biopsy with survival for head
and neck melanoma: survival analysis using the SEER database. JAMA
Otolaryngol Head Neck Surg. 140:1101–1109. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jones MP and Crowley J: A general class of
nonparametric tests for survival analysis. Biometrics. 45:157–170.
1989. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matetzky S, Shenkman B, Guetta V, Shechter
M, Beinart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D
and Hod H: Clopidogrel resistance is associated with increased risk
of recurrent atherothrombotic events in patients with acute
myocardial infarction. Circulation. 109:3171–3175. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hong KS: Dual antiplatelet therapy after
noncardioembolic ischemic stroke or transient ischemic attack: Pros
and cons. J Clin Neurol. 10:189–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen ZM, Jiang LX, Chen YP, Xie JX, Pan
HC, Peto R, Collins R and Liu LS: COMMIT (ClOpidogrel and
Metoprolol in Myocardial Infarction Trial) collaborative group.
Addition of clopidogrel to aspirin in 45,852 patients with acute
myocardial infarction: Randomised placebo-controlled trial. Lancet.
366:1607–1621. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mehta SR, Yusuf S, Peters RJ, Bertrand ME,
Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F,
Chrolavicius S, et al: Effects of pretreatment with clopidogrel and
aspirin followed by long-term therapy in patients undergoing
percutaneous coronary intervention: The PCI-CURE study. Lancet.
358:527–533. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sabatine MS, Cannon CP, Gibson CM,
López-Sendón JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill
KA, Skene AM, et al: Addition of clopidogrel to aspirin and
fibrinolytic therapy for myocardial infarction with ST-segment
elevation. N Engl J Med. 352:1179–1189. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sabatine MS, Cannon CP, Gibson CM,
López-Sendón JL, Montalescot G, Theroux P, Lewis BS, Murphy SA,
McCabe CH and Braunwald E: Clopidogrel as Adjunctive Reperfusion
Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28
Investigators. Effect of clopidogrel pretreatment before
percutaneous coronary intervention in patients with ST-elevation
myocardial infarction treated with fibrinolytics: The PCI-CLARITY
study. JAMA. 294:1224–1232. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Steinhubl SR, Berger PB, Mann JT III, Fry
ET, DeLago A, Wilmer C and Topol EJ: CREDO Investigators.
Clopidogrel for the Reduction of Events During Observation: Early
and sustained dual oral antiplatelet therapy following percutaneous
coronary intervention: A randomized controlled trial. JAMA.
288:2411–2420. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yusuf S, Zhao F, Mehta SR, Chrolavicius S,
Tognoni G and Fox KK: Clopidogrel in Unstable Angina to Prevent
Recurrent Events Trial Investigators: Effects of clopidogrel in
addition to aspirin in patients with acute coronary syndromes
without ST-segment elevation. N Engl J Med. 345:494–502. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mahmud T, Scott DL and Bjarnason I: A
unifying hypothesis for the mechanism of NSAID related
gastrointestinal toxicity. Ann Rheum Dis. 55:211–213. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ng SC and Chan FK: NSAID-induced
gastrointestinal and cardiovascular injury. Curr Opin
Gastroenterol. 26:611–617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sakumoto R, Hayashi KG and Takahashi T:
Different expression of PGE synthase, PGF receptor, TNF, Fas and
oxytocin in the bovine corpus luteum of the estrous cycle and
pregnancy. Reprod Biol. 14:115–121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Patrono C, Bachmann F, Baigent C, Bode C,
De Caterina R, Charbonnier B, Fitzgerald D, Hirsh J, Husted S,
Kvasnicka J, et al: Expert consensus document on the use of
antiplatelet agents. The task force on the use of antiplatelet
agents in patients with atherosclerotic cardiovascular disease of
the European society of cardiology. Eur Heart J. 25:166–181. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Twomley KM, Rao SV and Becker RC:
Proinflammatory, immunomodulating and prothrombotic properties of
anemia and red blood cell transfusions. J Thromb Thrombolysis.
21:167–174. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yasuda H, Yamada M, Sawada S, Endo Y,
Inoue K, Asano F, Takeyama Y and Yoshiba M: Upper gastrointestinal
bleeding in patients receiving dual antiplatelet therapy after
coronary stenting. Intern Med. 48:1725–1730. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ho PM, Maddox TM, Wang L, Fihn SD, Jesse
RL, Peterson ED and Rumsfeld JS: Risk of adverse outcomes
associated with concomitant use of clopidogrel and proton pump
inhibitors following acute coronary syndrome. JAMA. 301:937–944.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Juurlink DN, Gomes T, Ko DT, Szmitko PE,
Austin PC, Tu JV, Henry DA, Kopp A and Mamdani MM: A
population-based study of the drug interaction between proton pump
inhibitors and clopidogrel. CMAJ. 180:713–718. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gaglia MA Jr, Torguson R, Hanna N,
Gonzalez MA, Collins SD, Syed AI, Ben-Dor I, Maluenda G, Delhaye C,
Wakabayashi K, et al: Relation of proton pump inhibitor use after
percutaneous coronary intervention with drug-eluting stents to
outcomes. Am J Cardiol. 105:833–838. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gupta E, Bansal D, Sotos J and Olden K:
Risk of adverse clinical outcomes with concomitant use of
clopidogrel and proton pump inhibitors following percutaneous
coronary intervention. Dig Dis Sci. 55:1964–1968. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
CAPRIE Steering Committee: A randomised,
blinded, trial of clopidogrel versus aspirin in patients at risk of
ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet.
348:1329–1339. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheung J, Rajala J, Moroz D, Zhu Q, Stamm
M and Sandha GS: Acetylsalicylic acid use in patients with acute
myocardial infarction and peptic ulcer bleeding. Can J
Gastroenterol. 23:619–623. 2009. View Article : Google Scholar : PubMed/NCBI
|
